LeMaitre Vascular Inc (LMAT)
78.45
+0.77
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
78.37
-0.08
(-0.10%)
After-Hours: 20:00
LeMaitre Vascular Cash from Financing (Quarterly): 0.039M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.039M |
December 31, 2023 | -2.686M |
September 30, 2023 | -3.122M |
June 30, 2023 | 0.502M |
March 31, 2023 | -1.825M |
December 31, 2022 | -2.122M |
September 30, 2022 | -2.147M |
June 30, 2022 | -2.585M |
March 31, 2022 | -2.38M |
December 31, 2021 | -1.159M |
September 30, 2021 | 33.36M |
June 30, 2021 | -10.54M |
March 31, 2021 | -7.965M |
December 31, 2020 | -21.00M |
September 30, 2020 | -6.474M |
June 30, 2020 | 61.38M |
March 31, 2020 | -1.741M |
December 31, 2019 | -2.22M |
September 30, 2019 | 0.016M |
June 30, 2019 | -2.842M |
March 31, 2019 | 0.424M |
December 31, 2018 | -1.303M |
September 30, 2018 | 0.00 |
June 30, 2018 | -3.37M |
March 31, 2018 | 0.257M |
Date | Value |
---|---|
December 31, 2017 | -1.066M |
September 30, 2017 | 1.298M |
June 30, 2017 | -0.711M |
March 31, 2017 | 0.559M |
December 31, 2016 | -1.042M |
September 30, 2016 | -0.507M |
June 30, 2016 | -1.169M |
March 31, 2016 | 0.141M |
December 31, 2015 | 0.847M |
September 30, 2015 | 0.585M |
June 30, 2015 | 0.028M |
March 31, 2015 | -0.381M |
December 31, 2014 | -0.79M |
September 30, 2014 | -2.158M |
June 30, 2014 | 9.487M |
March 31, 2014 | 0.123M |
December 31, 2013 | 0.048M |
September 30, 2013 | -0.183M |
June 30, 2013 | -0.906M |
March 31, 2013 | 0.08M |
December 31, 2012 | -0.061M |
September 30, 2012 | -1.255M |
June 30, 2012 | -1.239M |
March 31, 2012 | -0.602M |
December 31, 2011 | -1.476M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-21.00M
Minimum
Dec 2020
61.38M
Maximum
Jun 2020
1.224M
Average
-2.184M
Median
Cash from Financing (Quarterly) Benchmarks
Baxter International Inc | -140.00M |
AtriCure Inc | -7.862M |
Becton Dickinson & Co | 1.705B |
Perspective Therapeutics Inc | 166.33M |
Xtant Medical Holdings Inc | 5.179M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 5.071M |
Cash from Investing (Quarterly) | -2.361M |
Free Cash Flow | 33.04M |
Free Cash Flow Per Share (Quarterly) | 0.164 |
Free Cash Flow to Equity (Quarterly) | 3.701M |
Free Cash Flow to Firm (Quarterly) | 3.701M |
Free Cash Flow Yield | 1.87% |